Digital Health Innovators: Senseonics’ Francine Kaufman In the most recent of the Health Innovators video series, pharmaphorum's founder, Dr Paul Tunnah, chats with the chief medical officer of Senseonics.
News Senseonics, TypeZero to develop artificial pancreas Deal will combine inControl algorithms with Eversense CGM.
News Senseonics' implantable glucose monitor passes test Company now looking to file for pre-marketing approval.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.